A retrospective study on effectiveness of combined recombinant human interferon-α-1b, interleukin-2, and thalidomide for the treatment of acute myeloid leukemia in various disease states

BACKGROUND: Interferon-α-1b, interleukin-2 combined with thalidomide (ITI) improved the outcome and prognosis of some acute myeloid leukemia (AML) patients, but the cases was insufficient. This study observed the efficacy and safety of this regimen in the treatment of numbers of AML patients in vari...

Descripción completa

Detalles Bibliográficos
Autores principales: Mi, Ruihua, Chen, Lin, Wang, Xiaojiao, Yin, Qingsong, Wang, Zhanfang, Ma, Xiaomiao, Xu, Yulin, Chen, Shuxia, Wang, Genjie, Yang, Haiping, Li, Zhichun, Wang, Huirui, Guo, Shuli, Zhao, Hongmian, Song, Qinglin, Li, Wenyong, Li, Jingdong, Wei, Xudong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9843385/
https://www.ncbi.nlm.nih.gov/pubmed/36660719
http://dx.doi.org/10.21037/atm-22-5520

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9843385/
https://www.ncbi.nlm.nih.gov/pubmed/36660719
http://dx.doi.org/10.21037/atm-22-5520

Ejemplares similares